Literature DB >> 11916309

The role of the innate and adaptive immune responses in Acanthamoeba keratitis.

Jerry Y Niederkorn1.   

Abstract

Infections of the corneal surface are an important cause of blindness. Protozoal, viral, bacterial, and helminthic infections of the cornea account for up to 9 million cases of corneal blindness. Free-living amoebae of the genus Acanthamoeba produce a progressive infection of the cornea called Acanthamoeba keratitis. Disease is usually transmitted by Acanthamoeba trophozoites bound to soft contact lenses. Infection of the cornea is initiated when the parasite binds to the corneal epithelial surface. Recrudescence can occur and suggests that the adaptive immune response is not aroused by corneal Acanthamoeba infections. Systemic immunization with Acanthamoeba antigens elicits robust Th1 cell-mediated immunity and serum IgG antibody, yet fails to prevent the development of Acanthamoeba keratitis. However, immunization via mucosal surfaces induces anti-Acanthamoeba IgA antibodies in the tears and provides solid protection against the development of Acanthamoeba keratitis. Unlike other immune effector mechanisms that rely on cytolysis, inflammation, release of toxic molecules, or the induction of host cell death, the adaptive immune apparatus prevents Acanthamoeba infections of the cornea by simply preventing the attachment of the parasite to the epithelial surface. The beauty of this mechanism lies in its exquisite simplicity and efficacy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916309

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  11 in total

Review 1.  Pathogenesis of acanthamoeba keratitis.

Authors:  Noorjahan Panjwani
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

Review 2.  Pattern recognition receptors in microbial keratitis.

Authors:  M-A Taube; M del Mar Cendra; A Elsahn; M Christodoulides; P Hossain
Journal:  Eye (Lond)       Date:  2015-07-10       Impact factor: 3.775

3.  IL-17A-mediated protection against Acanthamoeba keratitis.

Authors:  Amol Suryawanshi; Zhiyi Cao; James F Sampson; Noorjahan Panjwani
Journal:  J Immunol       Date:  2014-12-10       Impact factor: 5.422

4.  Characterisation and differentiation of pathogenic and non-pathogenic Acanthamoeba strains by their protein and antigen profiles.

Authors:  J Walochnik; K Sommer; A Obwaller; E-M Haller-Schober; H Aspöck
Journal:  Parasitol Res       Date:  2004-01-13       Impact factor: 2.289

Review 5.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 6.  The cornea IV immunology, infection, neovascularization, and surgery chapter 1: Corneal immunology.

Authors:  Hazem M Mousa; Daniel R Saban; Victor L Perez
Journal:  Exp Eye Res       Date:  2021-02-16       Impact factor: 3.467

7.  Double-biguanide therapy for resistant acanthamoeba keratitis.

Authors:  Giulio Ferrari; Stanislav Matuska; Paolo Rama
Journal:  Case Rep Ophthalmol       Date:  2011-11-05

8.  Pathogenic strains of Acanthamoeba are recognized by TLR4 and initiated inflammatory responses in the cornea.

Authors:  Hassan Alizadeh; Trivendra Tripathi; Mahshid Abdi; Ashley Dawn Smith
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

Review 9.  Pathobiology and Immunobiology of Acanthamoeba Keratitis: Insights from Animal Models
.

Authors:  Sudha Neelam; Jerry Y Niederkorn
Journal:  Yale J Biol Med       Date:  2017-06-23

10.  Quantitative proteomic analysis and functional characterization of Acanthamoeba castellanii exosome-like vesicles.

Authors:  Wei-Chen Lin; Chia-Yun Tsai; Jian-Ming Huang; Shang-Rung Wu; Lichieh Julie Chu; Kuo-Yang Huang
Journal:  Parasit Vectors       Date:  2019-10-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.